Organigram Agrees To Acquire Sanity For An Upfront Payment Of €113.4M Consisting Of €80M Cash And €33.4M In Shares, Sanity Is Entitled To Receive Milestone Payments Of Up To €113.8M

Organigram Global Inc. +0.70% Pre

Organigram Global Inc.

OGI

1.43

1.46

+0.70%

+2.10% Pre

Accretive Acquisition of Sanity Group Establishes Organigram as a Global Pure Play Cannabis Company with Leadership Positions in the World's Two Largest Federally Legal Cannabis Markets

  • Organigram to acquire Sanity Group for up-front consideration of €113.4 million plus a maximum earnout of up to €113.8 million tied to financial performance.
  • Proposed Acquisition of the Berlin‑based company unites two leaders in the largest federally legal cannabis markets, boosting commercial opportunities, strengthening access to best‑in‑class leadership, and expanding a valuable network of supply-chain partners.
  • Sanity is achieving top-line growth. Annual net revenue increased from €9 million in 2023 to €60 million in 2025, including €19 million generated in the fourth quarter of 2025.
  • Sanity Group operates Europe's first two legal cannabis specialty stores as part of scientific pilot projects in Switzerland.
  • Opportunity to capitalize on Sanity's near-term plans to enter the UK and Poland markets and expand on existing business in Czechia.
  • Opportunity to bring industry-leading IP generated by the Product Development Collaboration (PDC) as well as Organigram's products to emerging legal cannabis markets.
  • Organigram poised to sell significantly greater volumes of higher-margin flower into Europe with the ability to capture more of the value chain.
  • Acquisition is expected to be financed by a combination of cash on hand, proceeds from a new credit facility, and expected C$65.2 million equity investment by BAT.
This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.